Clinical Trials for EpimAb Biotherapeutics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: EpimAb Biotherapeutics

Clinical Trials (4)

NCT05607498
First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors or Relapse/Refractory Lymphoma
PHASE1Recruiting
150 participants
Started: Mar 1, 2023 · Completed: Mar 31, 2026
2 conditions1 sponsor10 locations
NCT05263180
A Study of EMB-09 in Participants With Advanced or Metastatic Solid Tumors.
PHASE1Recruiting
30 participants
Started: Jul 25, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor4 locations
NCT05176665
EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
PHASE1/PHASE2Recruiting
152 participants
Started: Oct 21, 2021 · Completed: Dec 31, 2025
3 conditions2 sponsors14 locations
NCT03797391
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
186 participants
Started: Dec 13, 2018 · Completed: Jan 15, 2026
3 conditions2 sponsors5 locations